Liver steatosis is a risk factor for hepatotoxicity in patients with inflammatory bowel disease under immunosuppressive treatment
Torsten Schröder(University Hospital Schleswig-Holstein), Jürgen Büning(University Hospital Schleswig-Holstein), Vera Olsen(Apple (Israel)), Klaus Fellermann(Apple (Israel)), Hendrik Lehnert(University of Salzburg), Steffen Möller(University of Rostock), Christian Sina(Khalifa University of Science and Technology), Klaus J. Schmidt(University Gastroenterology), Tilo Mackenroth(Apple (Israel))
Cited by 36
Related Papers
Reduced Paneth cell α-defensins in ileal Crohn's disease
|Proceedings of the National Academy of Sciences|2005|969
NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression
|Gut|2004|798
A Chromosome 8 Gene-Cluster Polymorphism with Low Human Beta-Defensin 2 Gene Copy Number Predisposes to Crohn Disease of the Colon
|The American Journal of Human Genetics|2006|566
NF-κB- and AP-1-Mediated Induction of Human Beta Defensin-2 in Intestinal Epithelial Cells by<i>Escherichia coli</i>Nissle 1917: a Novel Effect of a Probiotic Bacterium
|Infection and Immunity|2004|469
The Predictive Value of Different Measures of Obesity for Incident Cardiovascular Events and Mortality
|The Journal of Clinical Endocrinology & Metabolism|2010|465